The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Find out more about our and our members' work around the world.
A preventable, treatable form of cardiovascular disease
Home > About our Programmes > Rheumatic Heart Disease
This means that it imposes heavy costs on the health systems that can least afford it. If left untreated, rheumatic heart disease can lead to heart valve damage, stroke, heart failure, and death. Treatment of advanced disease requires costly surgery that is unavailable in many parts of the world. In endemic countries, prevalence of this preventable disease is a stark measure of health system failure and inequality.
RHD is the most commonly acquired heart disease in young people under the age of 25. It most often begins in childhood as strep throat, and can progress to serious heart damage that kills or debilitates adolescents and young adults, and makes pregnancy hazardous.
Although virtually eliminated in Europe and North America, the disease remains common in Africa, the Middle East, Central and South Asia, the South Pacific, and in impoverished pockets of developed nations.
around the world affected by RHD
RHD Action is a global initiative that unites and empowers the rheumatic heart disease community. Led by a coalition of core organizations, RHD Action shares technical advice, advocacy support, and policy insights with partners and allies across the world. Together, we work to create positive change and better health outcomes for people living with RHD and their communities.
Since co-founding RHD Action in 2015, the World Heart Federation’s work to prevent and control RHD has been channeled through this initiative, whose other founding members include RhEACH and Medtronic Philanthropy.
You can get involved in our work on rheumatic heart disease by visiting our website, signing up to our newsletter, following us on Twitter or using the hashtag #RHDAction.
annually by RHD
The RHD Action website contains a Resource Hub, which is the world’s largest repository of tools and resources for RHD. Materials are available in several languages, and include resources for health professionals, programme coordinators, advocates and people living with RHD. It also includes all resources previously available on the ‘RHD Net’ section of the World Heart Federation website. You can access the Resource Hub for free here.
If you have a resource that you would like to submit to the Resource Hub, please contact RHD Action at email@example.com.
RHD Action sends out a bi-monthly newsletter RHD Beat, which provides the latest global updates on RHD prevention and control. You can sign up here to subscribe to RHD Beat.
If you have a piece of news that you would like to submit to RHD Beat, please contact RHD Action at firstname.lastname@example.org.
To achieve its mission of reducing the global burden of rheumatic fever and rheumatic heart disease around the world, the World Heart Federation has set a specific goal:
Achieve a 25% reduction in premature deaths from RF and RHD among individuals aged <25 years by 2025.
WHO launches new report on the global tobacco epidemic
NOACs and fixed-dose combination antihypertensive medications added to WHO Essential Medicines List
WHF and partners call on UN Secretary General to reject proposal for a “more nuanced” relationship with tobacco industry
Diabetes & CVD: A Global Analysis
WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies
Policy and Reports